MYC and acute lymphoblastic leukemia: Recently, a variety of genetic lesions, including aberrant expression of TAL1, LYL1, and TLX1/HOX11 [4], activating mutations of NOTCH1[5, 6], and increased expression of c-MYC have been implicated in T-ALL pathogenesis [5, 7, 8].